Anthony S. Gibney - 18 Mar 2026 Form 3 Insider Report for InflaRx N.V. (IFRX)

Reporting relationship
Director
Issuer ticker
IFRX
Reported as of
18 Mar 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
18 Mar 2026, 08:16:04 UTC
Prior SEC filing
03 Mar 2026
Next SEC filing
16 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christian Schmid, Attorney-in-Fact

Key filing fact

Anthony S. Gibney filed Form 3 for InflaRx N.V. (IFRX) on 18 Mar 2026.

Key facts

  • This page summarizes Anthony S. Gibney's Form 3 filing for InflaRx N.V. (IFRX).
  • 0 reported transactions and 7 derivative rows are listed below.
  • Accepted by SEC: 18 Mar 2026, 08:16.

Change

  • Previous filing in this sequence was filed on 03 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001750132 Primary reporting owner

Gibney Anthony S

Relationship
Director
Address
C/O INFLARX N.V., WINZERLAER STREET 2, JENA, GERMANY
Signature
/s/ Christian Schmid, Attorney-in-Fact
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IFRX holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,000
Date
18 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IFRX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
11,667
Exercise price
$1.86
Footnotes
F1
IFRX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
16,418
Exercise price
$1.86
Footnotes
F2
IFRX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
30,000
Exercise price
$1.86
Footnotes
F3
IFRX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
30,000
Exercise price
$2.37
Footnotes
F4
IFRX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
30,000
Exercise price
$1.79
Footnotes
F5
IFRX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
30,000
Exercise price
$2.41
Footnotes
F6
IFRX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
30,000
Exercise price
$1.17
Footnotes
F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

This option was granted on February 7, 2018 and is fully vested and exercisable as of the date hereof.

Footnote F2

This option was granted on July 2, 2021 and is fully vested and exercisable as of the date hereof.

Footnote F3

This option was granted on January 12, 2022 and is fully vested and exercisable as of the date hereof.

Footnote F4

This option was granted on January 24, 2023 and is fully vested and exercisable as of the date hereof.

Footnote F5

This option was granted on January 5, 2024 and is fully vested and exercisable as of the date hereof.

Footnote F6

This option was granted on January 3, 2025 and is fully vested and exercisable as of the date hereof.

Footnote F7

This option was granted on January 6, 2026 and will vest and become exercisable in four equal installments of 7,500 shares on each quarterly anniversary of such grant date, subject to continued service through such dates.

SEC remarks

Exhibit List - Exhibit 24.1 Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .